Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events

Evid Based Med. 2013 Apr;18(2):73-4. doi: 10.1136/eb-2012-100787. Epub 2012 Aug 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Apolipoproteins B / blood*
  • Cardiovascular Diseases / epidemiology*
  • Cholesterol / blood*
  • Cholesterol, LDL / blood*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / drug therapy*

Substances

  • Anticholesteremic Agents
  • Apolipoproteins B
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol